Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hepac is a Dutch pharmaceutical manufacturing company and Darling Ingredients brand focused on producing high-quality, fully traceable crude porcine heparin from European-sourced intestinal mucosa. Its material is used by pharmaceutical manufacturers to produce heparin active pharmaceutical ingredient and low-molecular-weight heparins. The company emphasizes controlled sourcing, traceability, GMP-compliant operations, and regulatory inspection by Dutch authorities and the U.S. FDA. Hepac appears to operate as a commercial manufacturing and supply business rather than a drug developer with a disclosed therapeutic pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hepac.